These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31414269)

  • 1. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
    Abounahia FF; Abu-Jarir R; Abounahia MF; Al-Badriyeh D; Abushanab D; Abu-Ghalwa M; Mansour A; Kurdi B; Al-Rifai H
    Clin Drug Investig; 2019 Nov; 39(11):1093-1107. PubMed ID: 31414269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).
    Vento G; Paladini A; Aurilia C; Ozdemir SA; Carnielli VP; Cools F; Costa S; Cota F; Dani C; Davis PG; Fattore S; Fè C; Finer N; Fusco FP; Gizzi C; Herting E; Jian M; Lio A; Lista G; Mosca F; Nobile S; Perri A; Picone S; Pillow JJ; Polglase G; Pasciuto T; Pastorino R; Tana M; Tingay D; Tirone C; van Kaam AH; Ventura ML; Aceti A; Agosti M; Alighieri G; Ancora G; Angileri V; Ausanio G; Aversa S; Balestri E; Baraldi E; Barbini MC; Barone C; Beghini R; Bellan C; Berardi A; Bernardo I; Betta P; Binotti M; Bizzarri B; Borgarello G; Borgione S; Borrelli A; Bottino R; Bracaglia G; Bresesti I; Burattini I; Cacace C; Calzolari F; Campagnoli MF; Capasso L; Capozza M; Capretti MG; Caravetta J; Carbonara C; Cardilli V; Carta M; Castoldi F; Castronovo A; Cavalleri E; Cavigioli F; Cecchi S; Chierici V; Cimino C; Cocca F; Cocca C; Cogo P; Coma M; Comito V; Condò V; Consigli C; Conti R; Corradi M; Corsello G; Corvaglia LT; Costa A; Coscia A; Cresi F; Crispino F; D'Amico P; De Cosmo L; De Maio C; Del Campo G; Di Credico S; Di Fabio S; Di Nicola P; Di Paolo A; Di Valerio S; Distilo A; Duca V; Falcone A; Falsaperla R; Fasolato VA; Fatuzzo V; Favini F; Ferrarello MP; Ferrari S; Nastro FF; Forcellini CA; Fracchiolla A; Gabriele A; Galdo F; Gallini F; Gangemi A; Gargano G; Gazzolo D; Gentile MP; Ghirardello S; Giardina F; Giordano L; Gitto E; Giuffrè M; Grappone L; Grasso F; Greco I; Grison A; Guglielmino R; Guidotti I; Guzzo I; La Forgia N; La Placa S; La Torre G; Lago P; Lanciotti L; Lavizzari A; Leo F; Leonardi V; Lestingi D; Li J; Liberatore P; Lodin D; Lubrano R; Lucente M; Luciani S; Luvarà D; Maffei G; Maggio A; Maggio L; Maiolo K; Malaigia L; Mangili G; Manna A; Maranella E; Marciano A; Marcozzi P; Marletta M; Marseglia L; Martinelli D; Martinelli S; Massari S; Massenzi L; Matina F; Mattia L; Mescoli G; Migliore IV; Minghetti D; Mondello I; Montano S; Morandi G; Mores N; Morreale S; Morselli I; Motta M; Napolitano M; Nardo D; Nicolardi A; Nider S; Nigro G; Nuccio M; Orfeo L; Ottaviano C; Paganin P; Palamides S; Palatta S; Paolillo P; Pappalardo MG; Pasta E; Patti L; Paviotti G; Perniola R; Perotti G; Perrone S; Petrillo F; Piazza MS; Piccirillo A; Pierro M; Piga E; Pingitore GA; Pisu S; Pittini C; Pontiggia F; Pontrelli G; Primavera A; Proto A; Quartulli L; Raimondi F; Ramenghi L; Rapsomaniki M; Ricotti A; Rigotti C; Rinaldi M; Risso FM; Roma E; Romanini E; Romano V; Rosati E; Rosella V; Rulli I; Salvo V; Sanfilippo C; Sannia A; Saporito A; Sauna A; Scapillati E; Schettini F; Scorrano A; Mantelli SS; Sepporta V; Sindico P; Solinas A; Sorrentino E; Spaggiari E; Staffler A; Stella M; Termini D; Terrin G; Testa A; Tina G; Tirantello M; Tomasini B; Tormena F; Travan L; Trevisanuto D; Tuling G; Tulino V; Valenzano L; Vedovato S; Vendramin S; Villani PE; Viola S; Viola V; Vitaliti G; Vitaliti M; Wanker P; Yang Y; Zanetta S; Zannin E
    Trials; 2024 Jul; 25(1):433. PubMed ID: 38956676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
    van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil in Term and Premature Infants: A Systematic Review.
    Perez KM; Laughon M
    Clin Ther; 2015 Nov; 37(11):2598-2607.e1. PubMed ID: 26490498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
    BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants.
    Schulzke SM; Kaempfen S; Patole SK
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010018. PubMed ID: 25418278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.
    Suresh GK; Davis JM; Soll RF
    Cochrane Database Syst Rev; 2001; 2001(1):CD001968. PubMed ID: 11279743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide for respiratory failure in preterm infants.
    Barrington KJ; Finer NN
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000509. PubMed ID: 17636641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Walker E; Osborn DA
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.